C07K 5/06191
Containing heteroatoms different from o, s, or n
Official title: {containing heteroatoms different from O, S, or N}
C07K5/06191 (Containing heteroatoms different from o, s, or n) appears on 752 US grants and 473 published applications in this corpus.
Search patents in C07K- Granted patents
- 752
- Published applications
- 473
- Assignees
- 333
- Inventors
- 1,893
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 7 | 0 |
| 1978 | 13 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 7 | 0 |
| 1985 | 11 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 9 | 0 |
| 1989 | 13 | 0 |
| 1990 | 12 | 0 |
| 1991 | 10 | 0 |
| 1992 | 15 | 0 |
| 1993 | 12 | 0 |
| 1994 | 8 | 0 |
| 1995 | 24 | 0 |
| 1996 | 36 | 0 |
| 1997 | 43 | 0 |
| 1998 | 33 | 0 |
| 1999 | 37 | 0 |
| 2000 | 42 | 0 |
| 2001 | 26 | 7 |
| 2002 | 23 | 26 |
| 2003 | 36 | 41 |
| 2004 | 21 | 52 |
| 2005 | 25 | 34 |
| 2006 | 33 | 42 |
| 2007 | 18 | 18 |
| 2008 | 25 | 25 |
| 2009 | 21 | 24 |
| 2010 | 16 | 20 |
| 2011 | 14 | 15 |
| 2012 | 12 | 12 |
| 2013 | 15 | 12 |
| 2014 | 6 | 16 |
| 2015 | 13 | 11 |
| 2016 | 11 | 12 |
| 2017 | 6 | 12 |
| 2018 | 11 | 13 |
| 2019 | 5 | 15 |
| 2020 | 10 | 15 |
| 2021 | 10 | 15 |
| 2022 | 10 | 9 |
| 2023 | 6 | 7 |
| 2024 | 4 | 11 |
| 2025 | 5 | 6 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical use of ketoamide-based compound26 May 2026US 12,636,275 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Oligopeptide linker intermediate and preparation method thereof10 Mar 2026US 12,570,692 B2Mabplex International Co., Ltd.
- Delivery systems for controlled drug release16 Dec 2025US 12,497,417 B2Ladrx Corporation
- Macrocyclic compounds as proteasome inhibitors18 Nov 2025US 12,473,331 B2Cornell University
- Factor XIIA inhibitors24 Jun 2025US 12,336,991 B2University of Leeds
- Psma-targeted radiopharmaceuticals and dna damage response inhibitor combination therapy20 Aug 2026US 2026/0241048 A1Fusion Pharmaceuticals Inc.
- Solid state forms of fosgonimeton and salts thereof13 Aug 2026US 2026/0234183 A1Assia Chemical Industries Ltd.
- Aminopyrimidinyl derivatives for the treatment of parkinson's disease1 Jan 2026US 2026/0001875 A1University of Dundee
- Ras inhibitors4 Dec 2025US 2025/0368661 A1Revolution Medicines, Inc.
- Novel main protease inhibitors, and compositions and methods thereof23 Oct 2025US 2025/0326715 A1
Most cited
By later US patents
- Boronic ester and acid compounds, synthesis and uses183US 6,083,903 ALeukoSite, Inc. · 2000
- Boronic ester and acid compounds175US 5,780,454 AProScript, Inc. · 1998
- Hypotensive peptides and their use161US 4,548,926 ASankyo Company, Limited · 1985
- Phosphono/biaryl substituted dipetide derivatives149US 5,294,632 ACiba-Geigy Corporation · 1994
- .alpha.-Aminoboronic acid peptides142US 4,499,082 AE. I. Du Pont de Nemours and Company · 1985